The page is the record's research on the issuer — no analyst, no rating, no view. # FENNEC PHARMACEUTICALS INC. (NASDAQ: FENC) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is FENNEC PHARMACEUTICALS INC., listed on NASDAQ under ticker FENC. Its ISIN is US31447P1003. Its LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-A1 exists. Its security type is Corporate, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is British Columbia, Canada. Its segment is not on the record. Its status is listed, not halted. ## The disclosure read The record holds 131 filings in the window from 2025-11-08 to 2026-11-08, on 61 filing days. The median gap between filing days is 3.5 days. The latest filing is dated 2026-11-02 and is a directors_dealings filing, 6 days before the record date of 2026-11-08. The NASDAQ median cadence gap is 6.0 days across 4359 issuers, with a median of 52 filings and a median latency of 5.0 days. The 2836 Biological Products sector median cadence gap is 5.5 days across 176 issuers, with a median of 65.5 filings and a median latency of 4.0 days. The issuer's filings by type are 79 directors_dealings, 28 regulatory_filing, 12 corporate_news, 5 results, 3 prospectus, 2 agm_egm and 2 director_change. ## Auditor The auditor of record is HASKELL & WHITE LLP, located in Irvine, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001211583.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/FENC (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1211583/000110465926036182/fencf-20251231x10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/FENC (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/FENC · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp